Mayo finds convalescent plasma safe for diverse patients with COVID-19

Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findings — from the US Food and Drug Administration’s Expanded Access Program for COVID-19 — are reported in Mayo Clinic Proceedings.